TLSI
TriSalus Life SciencesCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-15
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
TLSI vs peer average
62/100
TLSI vs. peer average (C vs. D)
Grade spread
A 1 · B 2 · D 1 · F 5
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
GALT is the first available peer comparator.
Loose small-cap biotech comparator with liver-disease focus and event sensitivity, but not a PEDD/device-commercialization analogue; useful mainly for judging how clinical-readout and financing risk can dominate valuation at this cap range.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TLSI
TriSalus Life Sciences
GALT
Galectin Therapeutics
Grade
C
F
Momentum
89
2
Value
41
41
Sentiment
21
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs GALT
TLSI / GALT
Grade Position
In line
TLSI vs. peer average (C vs. D)
62/100
Momentum
89
TLSIValue
41
TLSISentiment
21
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TLSI
GALT is the first peer returned for this comparison set.